Cargando…
Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF-β/Smad and ERK signaling pathways
A wide range of therapeutic options exists for the treatment of keloids, all of which have their own strengths; however, a high risk of side-effects and frequent recurrence remains. Therefore, the present study aimed to identify improved therapeutic approaches or drugs for the treatment of keloids....
Autores principales: | Tang, Mengyao, Bian, Weiwei, Cheng, Liying, Zhang, Lu, Jin, Rong, Wang, Wenbo, Zhang, Yuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819908/ https://www.ncbi.nlm.nih.gov/pubmed/29328420 http://dx.doi.org/10.3892/ijmm.2018.3362 |
Ejemplares similares
-
The inhibitory effects of 20(R)-ginsenoside Rg3 on the proliferation, angiogenesis, and collagen synthesis of hypertrophic scar derived fibroblasts in vitro
por: Tang, Mengyao, et al.
Publicado: (2018) -
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways
por: Wang, Wenbo, et al.
Publicado: (2016) -
Melatonin influences the biological characteristics of keloid fibroblasts through the Erk and Smad signalling pathways
por: Huang, Shaobin, et al.
Publicado: (2023) -
Ginsenoside Rg2 alleviates myocardial fibrosis by regulating TGF-β1/Smad signalling pathway
por: Wang, Quanwei, et al.
Publicado: (2021) -
Electrospun Poly(L-Lactide) Fiber with Ginsenoside Rg3 for Inhibiting Scar Hyperplasia of Skin
por: Cui, Wenguo, et al.
Publicado: (2013)